DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,586,745 | +2.8% | 1,187,371 | -0.5% | 4.99% | +4.7% |
| Q2 2023 | $286,526,880 | +38.5% | 1,193,862 | +45.5% | 4.77% | +27.1% |
| Q1 2023 | $206,872,164 | -7.3% | 820,791 | -2.4% | 3.75% | -16.3% |
| Q4 2022 | $223,199,110 | +3.5% | 840,928 | +0.7% | 4.48% | -11.0% |
| Q3 2022 | $215,645,000 | -26.2% | 834,895 | -27.6% | 5.04% | -19.9% |
| Q2 2022 | $292,179,000 | -19.8% | 1,152,491 | -7.2% | 6.29% | -10.1% |
| Q1 2022 | $364,444,000 | -3.9% | 1,242,440 | +7.8% | 7.00% | -1.8% |
| Q4 2021 | $379,219,000 | +20.8% | 1,152,609 | +11.8% | 7.12% | -2.8% |
| Q3 2021 | $313,969,000 | +26.8% | 1,031,302 | +11.8% | 7.33% | +10.3% |
| Q2 2021 | $247,657,000 | +34.4% | 922,854 | +12.7% | 6.64% | +3.6% |
| Q1 2021 | $184,294,000 | +19.7% | 818,795 | +18.2% | 6.42% | -4.4% |
| Q4 2020 | $153,941,000 | +1.1% | 692,995 | -2.0% | 6.71% | -22.9% |
| Q3 2020 | $152,266,000 | +65.7% | 707,129 | +36.1% | 8.71% | +8.7% |
| Q2 2020 | $91,896,000 | +39.1% | 519,686 | +8.9% | 8.01% | -8.5% |
| Q1 2020 | $66,072,000 | +10.9% | 477,368 | +23.0% | 8.75% | +8.5% |
| Q4 2019 | $59,579,000 | – | 388,195 | – | 8.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |